Literature DB >> 15668931

Glutathione S-transferase polymorphisms and survival from head and neck cancer.

Stacy A Geisler1, Andrew F Olshan, Jianwen Cai, Mark Weissler, Joanna Smith, Douglas Bell.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the prognostic ability of polymorphisms of three genes involved in the metabolism of tobacco carcinogens (GSTT1, GSTM1, GSTP1) and one polymorphism of a DNA repair gene (XRCC1) for patients diagnosed with squamous cell carcinoma (SCC).
METHODS: Cox proportional hazard models were used to estimate risk of death for a prospective cohort of 190 patients.
RESULTS: Individuals with the GSTT1 functional genotype were twice as likely to die from any cause (hazard ratio [HR], 2.4; 95% confidence interval [CI], 1.13-4.97) and were three times as likely to die from SCC (HR, 3.4; 95% CI, 1.33-8.41) after adjustment for age, primary therapy, and stage of disease. The XRCC1 399 Gln genotype was predictive of disease recurrence.
CONCLUSIONS: Our findings, from one of the first studies to examine this research question, suggest that genomic markers of carcinogen metabolism and DNA repair capability may serve as prognostic indicators of disease recurrence and death. 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668931     DOI: 10.1002/hed.20141

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  11 in total

1.  MicroRNA-Related Genetic Variants Associated with Survival of Head and Neck Squamous Cell Carcinoma.

Authors:  Owen M Wilkins; Alexander J Titus; Lucas A Salas; Jiang Gui; Melissa Eliot; Rondi A Butler; Erich M Sturgis; Guojun Li; Karl T Kelsey; Brock C Christensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-06-07       Impact factor: 4.254

2.  ERCC1 C8092A polymorphism predicts fair survival outcome in Japanese patients with pharyngo-laryngeal squamous cell carcinoma.

Authors:  Hitoshi Hirakawa; Taro Ikegami; Satoe Azechi; Shinya Agena; Jin Uezato; Hidetoshi Kinjyo; Yukashi Yamashita; Katsunori Tanaka; Shunsuke Kondo; Hiroyuki Maeda; Mikio Suzuki; Akira Gahana
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-11-20       Impact factor: 2.503

Review 3.  Polymorphisms in DNA damage response genes and head and neck cancer risk.

Authors:  Rafael E Flores-Obando; Susanne M Gollin; Camille C Ragin
Journal:  Biomarkers       Date:  2010-08       Impact factor: 2.658

4.  The impact of GSTM1/GSTT1 polymorphism for the risk of oral cancer.

Authors:  Maximilian Krüger; Andreas Max Pabst; Benjamin Mahmoodi; Burkhard Becker; Peer Wolfgang Kämmerer; Felix Peter Koch
Journal:  Clin Oral Investig       Date:  2015-01-18       Impact factor: 3.573

5.  Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.

Authors:  Venkat R Katkoori; Xu Jia; Chakrapani Chatla; Sanjay Kumar; Selvarangan Ponnazhagan; Tom Callens; Ludwine Messiaen; William E Grizzle; Upender Manne
Journal:  Front Biosci       Date:  2008-01-01

6.  Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer.

Authors:  Jesse D Troy; Joel L Weissfeld; Brenda Diergaarde; Ada O Youk; Shama C Buch; Marjorie Romkes; Jennifer R Grandis
Journal:  Cancer Epidemiol       Date:  2013-03-21       Impact factor: 2.984

7.  N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.

Authors:  Semra Demokan; Yusufhan Suoglu; Mustafa Gözeler; Deniz Demir; Nejat Dalay
Journal:  Mol Biol Rep       Date:  2009-11-08       Impact factor: 2.316

8.  Translational medicine and reliability of single-nucleotide polymorphism studies: can we believe in SNP reports or not?

Authors:  Antonis Valachis; Davide Mauri; Christodoulos Neophytou; Nikolaos P Polyzos; Lampriani Tsali; Antonios Garras; Evangelos G Papanikolau
Journal:  Int J Med Sci       Date:  2011-08-24       Impact factor: 3.738

9.  ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer.

Authors:  Alec Vaezi; Chelsea H Feldman; Laura J Niedernhofer
Journal:  Pharmgenomics Pers Med       Date:  2011-07-20

10.  GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer.

Authors:  Xuemei Zhang; Maosheng Huang; Xifeng Wu; Susan Kadlubar; Jie Lin; Xinfeng Yu; Chunyang Fan; Baitang Ning; Fred F Kadlubar
Journal:  Pharmgenomics Pers Med       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.